Liminatus Pharma LIMN
NASDAQ LIMN
$3.14 -0.08 (-2.48%)
As of: Oct 21, 2026 · 10:13 AM EDT

Liminatus Pharma (LIMN) EBITDA (2025 - 2026)

Updated

Liminatus Pharma (LIMN) reported EBITDA of -$1.38 million for Q2 2026.

Analysis

Liminatus Pharma (LIMN) EBITDA (2025 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Liminatus Pharma's EBITDA came in at -$4.06 million; for FY2025, it was -$2.97 million.

  • Per Business Quant data, the three quarters before Q2 2026 came in at -$1.1 million (Q1 2026), -$883,668 (Q4 2025) and -$700,628 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Eli Lilly 1,128.06 Bn 1,096.64 Bn 19.71 Bn 12.29 Bn
2 Johnson & Johnson 615.47 Bn 534.00 Bn 17.26 Bn 9.10 Bn
3 AbbVie 504.80 Bn 477.91 Bn 12.70 Bn 8.33 Bn
4 Merck 368.45 Bn 322.83 Bn 12.21 Bn 999.00 Mn
5 Novartis Ag 298.44 Bn 262.43 Bn 11.24 Bn -
6 Astrazeneca 261.92 Bn 235.60 Bn 12.86 Bn 5.09 Bn
7 Amgen 236.10 Bn 191.50 Bn 7.24 Bn 4.63 Bn
8 Gilead Sciences 190.71 Bn 164.91 Bn 6.22 Bn -9.70 Bn
9 Pfizer 170.16 Bn 116.81 Bn 10.94 Bn 5.89 Bn
10 Liminatus Pharma 3.04 Mn -2.95 Mn - -1.38 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.38 Mn
Mar 31, 2026 -1.10 Mn
Dec 31, 2025 -883,668.00
Sep 30, 2025 -700,628.00
API Access

Liminatus Pharma EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=LIMN&period=max&api_key=YOUR_API_KEY